# Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis

> **NCT01977131** · PHASE1,PHASE2 · COMPLETED · sponsor: **Wei Yu** · enrollment: 10 (actual)

## Conditions studied

- Silicosis

## Interventions

- **OTHER:** Cells

## Key facts

- **NCT ID:** NCT01977131
- **Lead sponsor:** Wei Yu
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2013-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01977131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01977131, "Safety Study of Autologous Bone Marrow Stromal Cells With Modification by Hepatocyte Growth Factor to Treat Silicosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01977131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*